Israel expands in South America

David Artzi, the chairman of the Israel Export Institute, was in Columbia and Chile on Sunday as part of an Israeli business delegation working towards expanding economic cooperation in South America.

By MATTHEW KRIEGER
March 12, 2007 08:00

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

David Artzi, the chairman of the Israel Export Institute, was in Columbia and Chile on Sunday as part of an Israeli business delegation working towards expanding economic cooperation in South America. A combined 39 Israeli companies opened branches in Columbia and Chile over the last year, according to a report released by the Institute on Sunday. The Institute expects these companies to do approximately $10-15 million dollars of business during the next two years in the fields of communications, information technology, biotechnology and medical supplies. Israeli companies currently employ more than 600 workers in the two countries.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS